The United States said it will import cancer drug
manufactured in India to overcome the acute shortage of the medicine
used in treatment of ovarian, bone marrow and AIDS-related skin cancer.
Exercising its enforcement discretion, the Federal Drug Administration (FDA) said the chemotherapeutic drug Lipodox will be imported as an alternative to Doxil.
Doxil, it said, is used in multiple treatment regimens, including treatment of ovarian cancer after failure of platinum-based chemotherapy.
The drug is also indicated for use in AIDS-related Kaposi's sarcoma and multiple myeloma.
Exercising its enforcement discretion, the Federal Drug Administration (FDA) said the chemotherapeutic drug Lipodox will be imported as an alternative to Doxil.
Doxil, it said, is used in multiple treatment regimens, including treatment of ovarian cancer after failure of platinum-based chemotherapy.
The drug is also indicated for use in AIDS-related Kaposi's sarcoma and multiple myeloma.
No comments:
Post a Comment